{
  "nct_id": "NCT72105917",
  "indication": "Alzheimer's Disease",
  "phase": "Phase 3",
  "sample_size": 478,
  "duration_weeks": 11,
  "dropout_rate": 0.27,
  "primary_endpoints": [
    "Cognitive function"
  ],
  "secondary_endpoints": [
    "Cognitive function",
    "ADAS-Cog score"
  ],
  "blinding": "single-blind",
  "control_arm": "placebo",
  "outcome_summary": "Study trial terminated early due to safety signals.",
  "success": false,
  "failure_reason": "Unexpected safety findings"
}